Since launching as a spin-out from the University of Oxford in 2010, we have developed award-winning, AI-powered imaging biomarkers, assisting physicians across the world to make better life-saving decisions.
e-Stroke is a collection of tools that use our state-of-the-art AI algorithms to support doctors by providing real-time interpretation of brain scans to help guide treatment and transfer decisions for stroke patients, allowing more patients to get the right treatment, in the right place, at the right time.
Our proprietary software can uniquely generate critical information from simple brain scans that can help expand patient access to life-saving stroke treatments.
Our AI-powered advanced technology has been studied in a number of publications, providing technical validation and demonstrating health economic benefit, and has also been shown to improve stroke treatment rates, both thrombectomy and thrombolysis. Click here to learn more.
The e-Stroke Cloud is a service designed to optimize workflow across stroke networks by enabling access to pseudonymized scan results from anywhere, including on the e-Stroke Mobile app, a tool enabling clinicians to have quick, easy access to critical results, strengthening the connection between clinicians, facilitating faster treatment decisions.
Supported web browsers include IE 11, and current versions of Edge, Firefox, Chrome and iPad Safari. e-Stroke Mobile is compatible with both Android and iOS devices.
e-ASPECTS can detect and measure both Large Vessel Occlusion (LVO) and hyperdense volumes (which may indicate bleeding), automatically assess ASPECTS score and infarct volume in non-contrast CT images, with overlaid heatmaps for visual aid.
e-CTA standardizes the assessment of collaterals, with automatic LVO detection in CTA scans, and allows graphical visualization of CTA acquisition timing.
e-Mismatch automatically computes core, penumbra and mismatch ratio in CT Perfusion and MR images.
